Is Teladoc Health Accelerating Growth Through Global Expansion?
TDOC accelerates global growth as expanding international operations and rising overseas revenues bolster its profitability outlook.
Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit
TDOC posts wider year-over-year loss in Q3 as BetterHelp segment stumbles, but gains in international revenues help cushion the blow.
Hims & Hers Scales Technology-Enabled, Vertically Integrated Care
HIMS deepens its technology-enabled care model with new offerings in GLP-1 weight loss, hormone health, and custom treatments.
How is Teladoc Health Placed in the Growing Telemedicine Market?
Teladoc Health is expanding its AI-powered virtual care capabilities as the telemedicine market surges toward massive U.S. growth.
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health, Inc. ( NYSE:TDOC ) , the global leader in virtual care, today announced that it issued an inducement award to a new employee.
How to Play Teladoc Health Stock Post Q3 Results: Buy, Hold or Sell?
Teladoc Health's Q3 results beat estimates, but revenues dipped and losses widened, attributed to soft performance at BetterHelp.
Why Teladoc Stock Zoomed Almost 12% Higher in October
The company rounded out the month with a top-line beat in its third-quarter earnings.
Is This Beaten-Down Stock Finally on the Road to Recovery?
The company's headwinds don't seem to be going away.
Teladoc ( TDOC ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Oct. 29, 2025, at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Teladoc Health Posts Mixed Results For Q3, Shares Move Lower - Teladoc Health ( NYSE:TDOC )
Teladoc Health Inc ( NYSE:TDOC ) reported financial results for the third quarter after the closing bell on Wednesday. Here's a rundown of the telehealth company's report. Q3 Highlights: Teladoc reported third-quarter revenue of $626.44 million, beating analyst estimates of $625.91 million.
Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.
Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
Is there a glimmer of hope for either of these underperforming healthcare companies?
Hims & Hers Elevates Technology-Driven Healthcare Accessibility
HIMS boosts AI-led care with new technology chief, hormone therapies and a global push via its ZAVA acquisition.
Teladoc Health to Announce Third Quarter 2025 Financial Results - Teladoc Health ( NYSE:TDOC )
NEW YORK, Oct. 15, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health Inc. ( NYSE:TDOC ) , the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to review ...
Teladoc Health to Announce Third Quarter 2025 Financial Results
NEW YORK, Oct. 15, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health Inc. ( NYSE: TDOC ) , the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to ...
Can 4 Relative Price Strength Stocks Defy Market Swings?
UNFI, TDOC, SUPN and BRP shine with strong relative price strength, earnings momentum, and analyst upgrades amid volatile markets.
Teladoc Health Expands Clarity Platform With Workplace Safety Tool
TDOC enhances its Clarity platform with an AI-driven tool to help hospitals combat rising workplace violence incidents.
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?
HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.
Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems
New offering aims to address the growing threat of workplace violence in healthcare settings, building on Teladoc Health's suite of AI-enabled solutions.
Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems - Teladoc Health ( NYSE:TDOC )
NEW YORK, Oct. 14, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health ( NYSE:TDOC ) , the global leader in virtual care, today announced the launch of a new offering to help hospitals and health systems address workplace violence.
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
Why Teladoc Health ( TDOC ) Stock Is Trading Higher Wednesday - Teladoc Health ( NYSE:TDOC )
Shares of Teladoc Health Inc ( NYSE:TDOC ) are trading higher and trending Wednesday afternoon. Here's what investors need to know. What To Know: Evercore ISI analyst Elizabeth Anderson maintained her In-Line rating on the telehealth company on Wednesday and raised the price target to $9 from ...
Is Progyny ( PGNY ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Teladoc Health Stock Jumped 15% This Morning
A famous short-seller flipped bullish on Teladoc. But are they right about why the stock should soar?
Teladoc ( TDOC ) Shares Climb On Bullish Commentary From Citron Research - Teladoc Health ( NYSE:TDOC )
Shares of Teladoc Health Inc ( NYSE:TDOC ) are surging Friday morning after Citron Research posted bullish comments on the telehealth provider, asserting they were "not wrong, just early" on the stock's potential. The commentary sparked renewed investor interest, pushing the stock higher in early ...
Down 96% From Its Highs, Is Teladoc a Hidden Bargain or a Value Trap?
The investment thesis for the telemedicine company continues to get weaker.
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.
Hims & Hers Expands AI and Technology Focus to Advance Digital Care
HIMS boosts AI investment and appoints a new CTO as it advances personalized, technology-driven digital healthcare at scale.
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.
2 Beaten-Down Stocks to Avoid Right Now
These once high-flying stocks no longer seem to have promising prospects.
Why Is Teladoc ( TDOC ) Up 4.6% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TruLegal Appoints Tom Stephenson as Chief Revenue Officer to Accelerate Corporate Secondment Market Expansion
NEW YORK, Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- TruLegal, the AI-powered partner for trusted legal talent, today announced that Tom Stephenson has joined its executive leadership team as Chief Revenue Officer.
Hims & Hers Scales Growth Through Subscriptions and Care Expansion
HIMS fuels growth through subscriptions, expanding care offerings and building proprietary health infrastructure at scale.
Teladoc: A Telehealth Titan in Trouble?
Teladoc's stock has taken a nosedive, but is there hope for recovery? Our experts break down the company's performance and future potential in this insightful analysis.
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health - Teladoc Health ( NYSE:TDOC )
MELBOURNE, Australia, Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health TDOC, the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via virtual delivery.
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health
Telecare operates Australia's leading virtual care clinic and provides software solutions to the healthcare sector.
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?
HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
2 Stocks Down More Than 90% That Still Aren't Worth Buying
There's still considerable downside risk for these beaten-down companies.
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth
Hims & Hers stock fell sharply Tuesday after the company missed Q2 revenue estimates, despite strong growth and reaffirmed guidance.
Teladoc ( TDOC ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.July 29, 2025, 8:30 p.m. ETChief Executive Officer - Chuck DivitaContinue reading ...
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Teladoc ( TDOC ) Q2 Revenue Tops Estimates
Teladoc Health ( NYSE:TDOC ) , a virtual healthcare provider offering telemedicine and digital health services, released its second quarter earnings results on July 29, 2025, covering the period ending June 30. The most notable news from the release was that GAAP revenue reached $631.9 million, ...
Teladoc Health Reports Smaller-Than-Expected Q2 Loss, Revenue Tops Estimates - Teladoc Health ( NYSE:TDOC )
Teladoc reports second-quarter revenue of $631.9 million, beating analyst estimates of $623.1 million. Teladoc reports a second-quarter loss of 19 cents per share, beating analyst estimates for a loss of 25 cents per share. Get special access to three exclusive "Top 10 Stocks" power lists today, ...
HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now?
Hims & Hers and Teladoc Health are reshaping virtual care, but which has the edge in earnings growth and strategic expansion? Let's see.
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Applied Optoelectronics ( NASDAQ:AAOI ) , Arcutis Biotherapeutics ( NASDAQ:ARQT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Ryan Koontz initiated coverage on Applied Optoelectronics, Inc.
Healthy Returns: Researchers move closer to a universal cancer vaccine
University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings season is approaching.
The Zacks Analyst Blog Highlights Hims & Hers Health, Teladoc Health and American Well
HIMS accelerates global growth with ZAVA buyout, Canadian launch, and soaring EPS estimates pointing to 177.8% upside.
Hims & Hers Paves the Way for Global Digital Health Expansion
HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition?
OptimizeRx bets on EHR-linked messaging and geo-targeting to stand out, but scaling in a crowded digital health field remains key.
